C. Lopez-quintero, P. De-los-cobos, J. Hasin, and D. S. , Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), Drug Alcohol Depend, vol.115, issue.1-2, pp.120-150, 2011.

, United Nations Office on D, Crime: World Drug Report, 2015.

, United Nations Office on Drugs and Crime (UNODC), 2015.

S. Nielsen, L. Gowing, and P. Sabioni, Pharmacotherapies for cannabis dependence, Cochrane Database Syst Rev, vol.1, p.8940, 2019.

P. Sabioni, L. Foll, and B. , Psychosocial and pharmacological interventions for the treatment of cannabis use disorder, F1000Res, vol.7, p.173, 2018.

J. Manzanares, J. Corchero, and J. Romero, Pharmacological and biochemical interactions between opioids and cannabinoids

, Trends Pharmacol Sci, vol.20, issue.7, pp.287-94, 1999.

M. Haney, Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers, Neuropsychopharmacology, vol.32, issue.6, pp.1391-403, 2007.

M. Haney, A. Bisaga, and R. W. Foltin, Interaction between naltrexone and oral THC in heavy marijuana smokers, Psychopharmacology (Berl), vol.166, issue.1, pp.77-85, 2003.

M. Ranganathan, M. Carbuto, and G. Braley, Naltrexone does not attenuate the effects of intravenous ?9-tetrahydrocannabinol in healthy humans, Int J Neuropsychopharmacol, vol.15, issue.9, pp.1251-64, 2012.

M. Haney, R. D. Glass, and A. , Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers, Neuropsychopharmacology, vol.40, issue.11, pp.2489-98, 2015.

D. J. Rohsenow, R. Miranda, and J. E. Mcgeary, Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics, Exp Clin Psychopharmacol, vol.15, issue.3, pp.272-81, 2007.

J. C. Garbutt, A. B. Kampov-polevoy, and L. S. Kalka-juhl, Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial, JAMA Psychiatry, vol.73, issue.10, pp.1056-63, 2016.

S. Nielsen, P. Sabioni, L. Gowing, L. Foll, and B. , Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents, Handb Exp Pharmacol, 2019.

C. A. Brezing and F. R. Levin, The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal, Neuropsychopharmacology, vol.43, issue.1, pp.173-194, 2018.